|
Volumn 31, Issue 4, 2012, Pages 178-184
|
Niclosamide, an old antihelminthic agent, demonstrates antitumor activity by blocking multiple signaling pathways of cancer stem cells.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;
MULTIPROTEIN COMPLEX;
NICLOSAMIDE;
NOTCH RECEPTOR;
REACTIVE OXYGEN METABOLITE;
STAT3 PROTEIN;
TARGET OF RAPAMYCIN KINASE;
TOR COMPLEX 1;
ANIMAL;
CANCER STEM CELL;
CELL MOTION;
CELL PROLIFERATION;
DRUG EFFECT;
HUMAN;
METABOLISM;
METASTASIS;
NEOPLASM;
PATHOLOGY;
REVIEW;
SIGNAL TRANSDUCTION;
TUMOR CELL LINE;
WNT SIGNALING PATHWAY;
ANIMALS;
ANTINEOPLASTIC AGENTS;
CELL LINE, TUMOR;
CELL MOVEMENT;
CELL PROLIFERATION;
HUMANS;
MULTIPROTEIN COMPLEXES;
NEOPLASM METASTASIS;
NEOPLASMS;
NEOPLASTIC STEM CELLS;
NF-KAPPA B;
NICLOSAMIDE;
REACTIVE OXYGEN SPECIES;
RECEPTORS, NOTCH;
SIGNAL TRANSDUCTION;
STAT3 TRANSCRIPTION FACTOR;
TOR SERINE-THREONINE KINASES;
WNT SIGNALING PATHWAY;
|
EID: 84876710119
PISSN: 1000467X
EISSN: None
Source Type: Journal
DOI: 10.5732/cjc.011.10290 Document Type: Review |
Times cited : (114)
|
References (0)
|